Clinical Trial Update: Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase 2 study evaluating bevacizumab (Avastin) in combination with temozolomide and irinotecan for unresectable, multifocal glioblastoma multiforme and gliosarc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Avastin (bevacizumab)
• Irinotecan (Irinotecan)
• Temodar (Temozolomide)

Snippet

Sponsor: Katy Peters | Conditions: Glioblastoma Multiforme, Gliosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2013-08-12